OpenAlex
PricingAboutJobs
Log inGet started
Work

Velour trial biomarkers update: Impact of RAS, BRAF, and sidedness on aflibercept activity.

HTML

Year: 2017
Type: conference-abstract
Source: Journal of Clinical Oncology
DOI: 10.1200/jco.2017.35.15_suppl.3538
Authors: Pratyaksha Wirapati, Valentina Pomella, Ben Vandenbosch, Peter Kerr, Evaristo Maiello, Grahame Mark Jeffery, Razvan-Ovidiu D. Curca, Meinolf Karthaus, John A. Bridgewater, Anca C. Mihailov, Igor Kiss, Sandra Merino, Joseph James McKendrick, Zacharenia Saridaki, Xavier JA Sagaert, Sabine Tejpar
Institutions: SIB Swiss Institute of Bioinformatics, KU Leuven, Almac (United Kingdom), Casa Sollievo della Sofferenza, Christchurch Hospital, München Klinik Neuperlach, University College London, Masaryk Memorial Cancer Institute, Hospital Universitari Sant Joan de Reus, Eastern Health, Hellenic Society of Medical Oncology, Universitair Ziekenhuis Leuven
Language: English

Topic: Colorectal Cancer Treatments and Studies
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: aflibercept, metastatic colorectal cancer, RAS mutations, BRAF mutation, tumor sidedness, biomarkers, FOLFIRI, overall survival, progression-free survival, response rate, somatic mutations, gene expression profiling
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W4246064222
Cites:
Cited by: 60
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security